Corcept Therapeutics
CORT
#2078
Rank
A$13.65 B
Marketcap
A$129.63
Share price
1.71%
Change (1 day)
40.71%
Change (1 year)

Corcept Therapeutics (CORT) - Total assets

Total assets on the balance sheet as of September 2025 : A$1.23 Billion

According to Corcept Therapeutics 's latest financial reports the company's total assets are A$1.23 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Corcept Therapeutics - Total assets on balance sheet (from 2003 to 2025)

Total assets by year

Year Total assets Change
2024-12-31A$1.35 B48.14%
2023-12-31A$0.91 B6.4%
2022-12-31A$0.85 B46.68%
2021-12-31A$0.58 B-21.39%
2020-12-31A$0.74 B26.26%
2019-12-31A$0.58 B33.1%
2018-12-31A$0.44 B56.63%
2017-12-31A$0.28 B196.17%
2016-12-31A$95.38 M33.88%
2015-12-31A$71.24 M68.37%
2014-12-31A$42.31 M-40.16%
2013-12-31A$70.71 M-25.89%
2012-12-31A$95.42 M145.64%
2011-12-31A$38.84 M57.19%
2010-12-31A$24.71 M-9.42%
2009-12-31A$27.28 M-2.65%
2008-12-31A$28.02 M38.1%
2007-12-31A$20.29 M61.57%
2006-12-31A$12.56 M-69.52%
2005-12-31A$41.21 M-33.24%
2004-12-31A$61.73 M289.49%
2003-12-31A$15.84 M-59.03%
2002-12-31A$38.68 M-18.62%
2001-12-31A$47.53 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
A$290.28 B 23,311.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$145.86 B 11,663.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$161.52 B 12,926.72%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
A$173.03 B 13,855.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$314.24 B 25,243.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$195.03 B 15,629.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$0.54 B-55.80%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
A$0.74 B-39.94%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$11.46 B 824.58%๐Ÿ‡บ๐Ÿ‡ธ USA